{"id":"W2168505126","doi":"10.1016/s0140-6736(09)60140-9","title":"Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":583,"is_retracted":false,"has_abstract":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Placebo; Psoriasis; Internal medicine; Clinical endpoint; Arthritis; Crossover study; Randomization; Secukinumab; Placebo-controlled study; Gastroenterology; Randomized controlled trial; Double blind; Dermatology; Rheumatoid arthritis; Pathology; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005859596,0.0003440497,0.001638002,0.00007788318,0.0004450201,0.0001247294,0.0002388574,0.0001223312,0.0001331168],"category_scores_gemma":[0.0001377707,0.0002196714,0.0005255206,0.0001064582,0.0001157078,0.00009360201,0.00004461761,0.0002477056,0.0000673939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000900591,"about_ca_system_score_gemma":0.00006575422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005041367,"about_ca_topic_score_gemma":0.0001514828,"domain_scores_codex":[0.9979234,0.00007480091,0.0006225738,0.0003938692,0.0003401565,0.0006451714],"domain_scores_gemma":[0.998691,0.0002721013,0.0002363976,0.0005934353,0.00009206226,0.0001149619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9801341,0.0004324202,0.0001401833,0.00002548315,0.0007268806,0.00006919759,0.0003791345,0.000004397967,0.0002714757,0.00126389,0.01269624,0.00385658],"study_design_scores_gemma":[0.9835399,0.002549154,0.0006142224,0.0002459697,0.0004900629,0.00007741387,0.00009395483,0.00005586605,0.0001878251,0.001636876,0.01028743,0.0002213093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9732418,0.003261681,0.00009297836,0.004076682,0.001065734,0.009528166,0.00008553423,0.0001365615,0.008510831],"genre_scores_gemma":[0.9882785,0.0004435675,0.0002587144,0.001243985,0.00570405,0.001157049,0.000175373,0.00003691635,0.002701828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01503668,"threshold_uncertainty_score":0.8957939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05254111303542622,"score_gpt":0.354957799294689,"score_spread":0.3024166862592628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}